Protocol for Specimens of Primary Penile Cancer



Protocol for Specimens of Primary Penile Cancer






















































































































































































































































































































































































































































































































































































































































































































































































Penis: Incisional Biopsy, Excisional Biopsy, Partial Penectomy, Total Penectomy, Circumcision


Surgical Pathology Cancer Case Summary (Checklist)


Procedure



____ Incisional biopsy



____ Excisional biopsy



____ Partial penectomy



____ Total penectomy



____ Circumcision



____ Other (specify): ______________________________



____ Not specified


Foreskin (Presence and Type) (select all that apply)



____ Present (uncircumcised)




*____ Short




*____ Medium




*____ Long




*____ Phimotic



____ Not identified (circumcised)



____ Cannot be determined


Lymphadenectomy



____ Not applicable



____ Sentinel node biopsy



____ Inguinal (superficial and deep)



____ External iliac



____ Pelvic nodes



____ Other (specify): _____________________________


Lymph Node Sampling



Number of involved lymph nodes: __________



Total number of lymph nodes examined: __________



Specimen Size



Specify: __________ x __________ cm


Tumor Site (if multiple sites are involved, select all that apply)



____ Glans



____ Foreskin mucosal surface



____ Foreskin skin surface



____ Coronal sulcus (balanopreputial sulcus)



____ Skin of the shaft



____ Penile urethra


Tumor Size



Greatest dimension: __________ cm



*Additional dimensions: _________ x _____ cm


*Tumor Focality



*____ Unicentric



*____ Multicentric


*Tumor Macroscopic Features (select all that apply)



*____ Flat



*____ Ulcerated



*____ Polypoid



*____ Verruciform



*____ Necrosis



*____ Hemorrhage



*____ Other (specify): _____________________________


*Tumor Deep Borders (select all that apply)



*____ Pushing (broadly base)



*____ Infiltrative (jagged)



*____ Other (specify): _____________________________


*Macroscopic Extent of Tumor (select all that apply)



*In the glans




*____ Tumor involves lamina propria




*____ Tumor involves corpus spongiosum




*____ Tumor involves tunica albuginea




*____ Tumor involves corpus cavernosum




*____ Tumor involves distal (penile) urethra




*____ Not applicable




*In the foreskin




*____ Tumor involves lamina propria




*____ Tumor involves dartos




*____ Tumor involves preputial skin




*____ Not applicable



*In the shaft




*____ Tumor involves skin




*____ Tumor involves dartos




*____ Tumor involves Buck fascia




*____ Tumor involves corpus spongiosum




*____ Tumor involves corpus cavernosum




*____ Tumor involves proximal urethra




*____ Not applicable


Macroscopic Assessment of Resection Margins (select all that apply)



____ Cannot be assessed



____ Grossly uninvolved



____ Grossly involved (specify for penectomy or circumcision specimen below)



For penectomy specimens




____ Urethral




____ Periurethral tissues (lamina propria, corpus spongiosum, Buck fascia)




____ Corpora cavernosa




____ Buck fascia at penile shaft




____ Skin



____ Other (specify): __________________



For circumcision specimens




____ Coronal sulcus margin




____ Cutaneous margin


Histologic Type (select all that apply)



____ Squamous cell carcinoma (SCC)




____ Usual (keratinizing)




____ Basaloid




____ Verrucous




*____ Cuniculatum




*____ Papillary, not otherwise specified (NOS)




____ Sarcomatoid




*____ Pseudohyperplastic




*____ Acantholytic (pseudoglandular)




*____ Mixed SCCs




____ Adenosquamous



____ Primary neuroendocrine carcinoma



____ Paget disease



____ Adnexal carcinoma (specify type): __________________________



Clear cell carcinoma



____ Carcinoma, type cannot be determined



____ Other (specify): _____________________________


Histologic Grade



____ Not applicable



____ GX: Cannot be assessed



____ G1: Well differentiated



____ G2: Moderately differentiated



____ G3: Poorly differentiated


Microscopic Tumor Extension (select all that apply)



Anatomical levels




In the glans





____ Tumor involves lamina propria





____ Tumor involves corpus spongiosum





____ Tumor involves tunica albuginea





____ Tumor involves corpus cavernosum





____ Not applicable




In the coronal sulcus





____ Tumor involves lamina propria





____ Tumor involves dartos





____ Tumor involves Buck fascia





____ Not applicable




In the foreskin





____ Tumor involves lamina propria





____ Tumor involves dartos





____ Tumor involves preputial skin





____ Not applicable




In the shaft





____ Tumor involves skin





____ Tumor involves dartos





____ Tumor involves Buck fascia





____ Tumor involves corpus spongiosum





____ Tumor involves corpus cavernosum





____ Not applicable




Other extension





____ Penile (distal) urethra





____ Proximal urethra





____ Prostate





____ Scrotum





____ Regional skin (pubis, inguinal)


*Tumor Thickness/Depth



*Specify: __________ mm


Margins of Resection (select all that apply)



____ Cannot be assessed



____ Histologically uninvolved



____ Histologically involved (specify for penectomy or circumcision specimens below)



For penectomy specimens




____ Urethral




____ Periurethral tissues (lamina propria, corpus spongiosum, Buck fascia)




____ Corpus cavernosum




____ Buck fascia at penile shaft




____ Skin




____ Other (specify): _____________________________



For circumcision specimens




____ Coronal sulcus margin




____ Cutaneous margin


Lymph-Vascular Invasion



____ Not identified



____ Present



____ Indeterminate


Perineural Invasion



____ Not identified



____ Present



____ Indeterminate


Pathologic Staging (pTNM)



TNM descriptors (required only if applicable) (select all that apply)




____ m (multiple primary tumors)




____ r (recurrent)




____ y (posttreatment)



Primary tumor (pT)




____ pTX: Primary tumor cannot be assessed




____ pT0: No evidence of primary tumor




____ pTis: Carcinoma in situ




____ pTa: Noninvasive verrucous carcinoma†




____ pT1a: Tumor invades subepithelial connective tissue without lymph vascular invasion and is not poorly differentiated (i.e., grade 3-4)




____ pT1b: Tumor invades subepithelial connective tissue with lymph vascular invasion or is poorly differentiated




____ pT2: Tumor invades corpus spongiosum or cavernosum




____ pT3: Tumor invades urethra




____ pT4: Tumor invades other adjacent structures




†Broad pushing penetration (invasion) is permitted, but destructive invasion argues against this diagnosis.



Regional lymph nodes (pN)




____ pNX: Regional lymph nodes cannot be assessed




____ pN0: No regional lymph node metastasis




____ pN1: Metastasis in a single inguinal lymph node




____ pN2: Metastasis in multiple or bilateral inguinal lymph nodes




____ pN3: Extranodal extension of lymph node metastasis or pelvic lymph node(s) unilateral or bilateral



Distant metastasis (pM)




____ Not applicable




____ pM1: Distant metastasis†




†Lymph node metastasis outside of the true pelvis in addition to visceral or bone sites


*Additional Pathologic Findings (select all that apply)



*____ None identified



*____ Penile intraepithelial neoplasia (PeIN)




*____ Differentiated (simplex)




*____ Warty




*____ Basaloid




*____ Mixed (warty/basaloid)




*____ Other (specify): ___________________________




*____ Focal




*____ Multifocal




*____ Margins uninvolved




*____ Margins involved (specify margin): _____________________________



*____ Lichen sclerosus



*____ Squamous hyperplasia



*____ Condyloma acuminatum



*____ Other (specify): _____________________________


*Ancillary Studies



*Specify: _____________________________



*____ Not performed


* Data elements with asterisks are not required. However, these elements may be clinically important but are not yet validated or regularly used in patient management. Adapted with permission from College of American Pathologists, “Protocol for the Examination of Specimens from Patients with Carcinoma of the Penis.” Under development.



Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 7, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Protocol for Specimens of Primary Penile Cancer

Full access? Get Clinical Tree

Get Clinical Tree app for offline access